Press Release
AimedBio Secures Pre-IPO Funding Round
2025.06.02
- AimedBio has secured a pre-IPO funding round totaling USD 38 million.
- - Including the previous Series B financing of USD 46 million, the company’s cumulative funding has reached USD 84 million.
- - The newly secured capital will be used to accelerate next-generation ADC pipeline development and prepare for global clinical entry.